Reports
Reports
Sale
The global saxagliptin market is expected to grow at a CAGR of 4% in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for saxagliptin is being driven by the rising cases of diabetes across the globe. North America and Europe are the significant markets for saxagliptin globally. This is attributed to a large number of ageing population and the rising prevalence of type II diabetes. The Asia Pacific region is expected to witness a robust growth rate in the forecast period. Countries, especially China and India, are predicted to exhibit a high growth rate of the saxagliptin industry in the Asia Pacific region. Factors such as increasing healthcare expenditure, a large pool of patients, and rising government funding are contributing to the market growth of saxagliptin in the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Saxagliptin is the medicine used to treat diabetes. It works by boosting the level of insulin in the body produced after the meal. The product is marketed under the brand name called Onglyza. Saxagliptin acts on a natural hormone in the body, which is called incretins. The product has various side effects such as urinary tract infection, headache, upper respiratory tract infection, and nasopharyngitis. Saxagliptin can also cause complications like stroke and heart attack.
On the basis of dosage, the market is divided into:
Based on distribution channel, the industry can be segmented into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for saxagliptin is being driven by the rising incidences of type II diabetes across the globe. The market drivers, such as increased sedentary lifestyle, rising prevalence of obesity, increased government funding, and junk food habits, are contributing to the market growth of saxagliptin. Further, the rising healthcare awareness is expected to fuel the market growth over the forecast period. The market is expanding due to further innovations taking place in the saxagliptin industry. This is further expected to aid the market growth over the forecast period. However, the market is expected to witness a setback owing to the factors, such as stringent regulations for the approval of drugs and the availability of substitutes for the treatment of diabetes.
The report gives a detailed analysis of the following key players in the global saxagliptin market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Dosage |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Saxagliptin Market Analysis
8.1 Key Industry Highlights
8.2 Global Saxagliptin Historical Market (2018-2023)
8.3 Global Saxagliptin Market Forecast (2024-2032)
8.4 Global Saxagliptin Market by Dosage
8.4.1 2.5 mg
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 5 mg
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Others
8.5 Global Saxagliptin Market by Distribution Channel
8.5.1 Hospital Pharmacy
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Retail Pharmacy
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Others
8.6 Global Saxagliptin Market by Region
8.6.1 North America
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Europe
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Asia Pacific
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.6.4 Latin America
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2017-2021)
8.6.4.3 Forecast Trend (2022-2027)
8.6.5 Middle East and Africa
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2017-2021)
8.6.5.3 Forecast Trend (2022-2027)
9 North America Saxagliptin Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2017-2021)
9.1.3 Forecast Trend (2022-2027)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2017-2021)
9.2.3 Forecast Trend (2022-2027)
10 Europe Saxagliptin Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2017-2021)
10.1.3 Forecast Trend (2022-2027)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2017-2021)
10.2.3 Forecast Trend (2022-2027)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2017-2021)
10.3.3 Forecast Trend (2022-2027)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2017-2021)
10.4.3 Forecast Trend (2022-2027)
10.5 Others
11 Asia Pacific Saxagliptin Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2017-2021)
11.1.3 Forecast Trend (2022-2027)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2017-2021)
11.2.3 Forecast Trend (2022-2027)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2017-2021)
11.3.3 Forecast Trend (2022-2027)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2017-2021)
11.4.3 Forecast Trend (2022-2027)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2017-2021)
11.5.3 Forecast Trend (2022-2027)
11.6 Others
12 Latin America Saxagliptin Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2017-2021)
12.1.3 Forecast Trend (2022-2027)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2017-2021)
12.2.3 Forecast Trend (2022-2027)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2017-2021)
12.3.3 Forecast Trend (2022-2027)
12.4 Others
13 Middle East and Africa Saxagliptin Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2017-2021)
13.1.3 Forecast Trend (2022-2027)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2017-2021)
13.2.3 Forecast Trend (2022-2027)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2017-2021)
13.3.3 Forecast Trend (2022-2027)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2017-2021)
13.4.3 Forecast Trend (2022-2027)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 AstraZeneca plc.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Wellona Pharma
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Saxagliptin Market: Key Industry Highlights, 2018 and 2032
2. Global Saxagliptin Historical Market: Breakup by Dosage (USD Million), 2018-2023
3. Global Saxagliptin Market Forecast: Breakup by Dosage (USD Million), 2024-2032
4. Global Saxagliptin Historical Market: Breakup by Distribution Channel (USD Million), 2018-2023
5. Global Saxagliptin Market Forecast: Breakup by Distribution Channel (USD Million), 2024-2032
6. Global Saxagliptin Historical Market: Breakup by Region (USD Million), 2018-2023
7. Global Saxagliptin Market Forecast: Breakup by Region (USD Million), 2024-2032
8. North America Saxagliptin Historical Market: Breakup by Country (USD Million), 2018-2023
9. North America Saxagliptin Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Europe Saxagliptin Historical Market: Breakup by Country (USD Million), 2018-2023
11. Europe Saxagliptin Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific Saxagliptin Historical Market: Breakup by Country (USD Million), 2018-2023
13. Asia Pacific Saxagliptin Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Latin America Saxagliptin Historical Market: Breakup by Country (USD Million), 2018-2023
15. Latin America Saxagliptin Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Middle East and Africa Saxagliptin Historical Market: Breakup by Country (USD Million), 2018-2023
17. Middle East and Africa Saxagliptin Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Global Saxagliptin Market Structure
The global saxagliptin market is projected to grow at a CAGR of 4% between 2024 and 2032.
The major drivers of the industry, such as rising disposable incomes, increasing population, rising prevalence of diabetes, a growing number of ageing population, rising healthcare expenditure, large pool of patients, increasingly sedentary lifestyle, and growing prevalence of obesity, are expected to aid the market growth.
The key trends guiding the growth of the market include the rising innovations and increasing government funding.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading dosages of saxagliptin in the market are 2.5 mg and 5 mg, among others.
The major distribution channels in the industry are hospital pharmacy and retail pharmacy, among others.
The major players in the industry are AstraZeneca plc. and Wellona Pharma, among others.
The global saxagliptin market is being driven by the rising prevalence of diabetes. Aided by the rising innovations in the industry, the market is expected to witness a moderate growth in the forecast period of 2024-2032, growing at a CAGR of 4%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on dosage, the market is segmented into 2.5 mg and 5 mg, among others. On the basis of distribution channel, the industry is divided into hospital pharmacy and retail pharmacy, among others. The major regional markets for saxagliptin are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include AstraZeneca plc. and Wellona Pharma, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.